Annotation Detail
Information
- Associated Genes
- BRAF
- Associated Variants
-
BRAF p.Gly509Ter (p.G509*)
(
ENST00000288602.11,
ENST00000496384.7,
ENST00000644969.2,
ENST00000646891.2 )
BRAF p.Gly509Arg (p.G509R) ( ENST00000288602.11, ENST00000496384.7, ENST00000644969.2, ENST00000646891.2 )
BRAF p.Gly509Arg (p.G509R) ( ENST00000288602.11, ENST00000496384.7, ENST00000644969.2, ENST00000646891.2 )
BRAF p.Gly509Ter (p.G509*) ( ENST00000288602.11, ENST00000496384.7, ENST00000644969.2, ENST00000646891.2 )
BRAF p.Gly509Arg (p.G509R) ( ENST00000288602.11, ENST00000496384.7, ENST00000644969.2, ENST00000646891.2 )
BRAF p.Gly509Arg (p.G509R) ( ENST00000288602.11, ENST00000496384.7, ENST00000644969.2, ENST00000646891.2 ) - Associated Disease
- Non-small cell lung carcinoma
- Source Database
- DisGeNET
- Description
- We present a case report of a patient with NSCLC and the BRAF G469R mutation who showed a dramatic response to sorafenib.
- Pubmed
- 26237499
- Original source reporting the Gene Disease association
- BeFree
- DisGENET score for the Gene Disease association
- 0.130510288141011
- Year of publication
- 2015
Drugs